Literature DB >> 11048840

Methylene blue-induced hyperbilirubinemia in neonatal glucose-6-phosphate dehydrogenase (G6PD) deficiency.

T W Gauthier1.   

Abstract

Methylene blue continues to be used in the gravid female. We report three premature neonates exposed to methylene blue that experienced severe hemolytic reactions requiring exchange transfusions. Two neonates were subsequently diagnosed with G6PD deficiency. Continued caution is warranted prior to the use of methylene blue in the gravid female.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11048840     DOI： 10.1002/1520-6661(200007/08)9:4<252::AID-MFM14>3.0.CO;2-U

Source DB:  PubMed          Journal:  J Matern Fetal Med        ISSN： 1057-0802


  5 in total

1.  PharmGKB summary: methylene blue pathway.

Authors:  Ellen M McDonagh; José M Bautista; Ilan Youngster; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2013-09       Impact factor: 2.089

Review 2.  Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.

Authors:  Ilan Youngster; Lidia Arcavi; Renata Schechmaster; Yulia Akayzen; Hen Popliski; Janna Shimonov; Svetlana Beig; Matitiahu Berkovitch
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.228

3.  Is there a need for neonatal screening of glucose-6-phosphate dehydrogenase deficiency in Canada?

Authors:  Aaron Leong
Journal:  Mcgill J Med       Date:  2007-01

Review 4.  G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications.

Authors:  Lucio Luzzatto; Elisa Seneca
Journal:  Br J Haematol       Date:  2013-12-28       Impact factor: 6.998

Review 5.  Efficacy and safety of methylene blue in the treatment of malaria: a systematic review.

Authors:  G Lu; M Nagbanshi; N Goldau; M Mendes Jorge; P Meissner; A Jahn; F P Mockenhaupt; O Müller
Journal:  BMC Med       Date:  2018-04-25       Impact factor: 8.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.